To include your compound in the COVID-19 Resource Center, submit it here.

Truvada emtricitabine/tenofovir regulatory update

The AIDS Healthcare Foundation (Los Angeles, Calif.) sent a letter signed by 55 U.S. physicians to FDA urging the agency to not approve Truvada emtricitabine/tenofovir as pre-exposure prophylaxis for HIV infection. The letter

Read the full 337 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE